Liquidation Sale Biotinylated Human Hla-a*02:03&b2m&afp (fmnkfiyei) Monomer Protein (mhc-hm432b) Accessory [rh1zsbt3]

Biotinylated Human HLA-A*02:03&B2M&AFP Monomer Protein

Introducing the Biotinylated Human HLA-A*02:03&B2M&AFP (FMNKFIYEI) Monomer Protein, a cutting-edge research tool designed for immunology and molecular biology applications. This high-quality protein is a monomer, making it ideal for various experimental setups. With its biotinylated form, it offers enhanced binding capabilities, allowing for more precise and sensitive assays. The Biotinylated Human HLA-A*02:03&B2M&AFP Monomer Protein is a must-have for researchers seeking to advance their studies in the fields of immunology, virology, and oncology.

• High purity and consistent quality ensure reliable results
• Optimized for use in ELISA, Western blot, and flow cytometry assays
• Conveniently packaged for easy storage and handling

Product Properties and Specifications

The Biotinylated Human HLA-A*02:03&B2M&AFP Monomer Protein is produced through a proprietary expression system, ensuring high purity and stability. This protein is specifically designed for use in immunoassays, where its biotinylated nature facilitates strong binding to secondary antibodies. The protein's molecular weight is approximately 28 kDa, and it contains the key epitope FMNKFIYEI, which is essential for recognizing and studying HLA-A*02:03. The product is supplied as a lyophilized powder, ready for reconstitution with sterile water or buffer, making it user-friendly and convenient for researchers.

• Lyophilized powder for easy storage and reconstitution
• Contains the key epitope FMNKFIYEI for specific binding
• Supplied with detailed product information and usage instructions

Practical Applications and Benefits

The Biotinylated Human HLA-A*02:03&B2M&AFP Monomer Protein is a versatile tool for a wide range of research applications. It is particularly useful in studying antigen presentation, immune response, and vaccine development. Researchers in academia and industry can leverage this protein to advance their studies in the following areas:

• Immunology research: Investigate the role of HLA-A*02:03 in immune response and disease
• Biotechnology: Develop new diagnostic and therapeutic strategies for cancer and infectious diseases
• Drug discovery: Screen for potential drug candidates targeting HLA-A*02:03

By using the Biotinylated Human HLA-A*02:03&B2M&AFP Monomer Protein, researchers can gain valuable insights into the complex mechanisms of the immune system and contribute to the development of innovative treatments for a variety of diseases.